Introduction
============

In middle-aged populations, differences between males and females are described in terms of various aspects of coronary artery diseases. Males, for example, have a higher rate of previous myocardial infarction (MI).[@b1-cia-11-1309],[@b2-cia-11-1309] Females, at least in some studies, have been reported to have a longer delay to reach hospital and less frequently to receive invasive therapy for acute myocardial infarction (AMI) than males.[@b3-cia-11-1309],[@b4-cia-11-1309] In addition, females develop symptomatic cardiovascular disease about a decade later in life than males do.[@b5-cia-11-1309] Age is a demographic predictor of short- and long-term mortality in AMI.[@b6-cia-11-1309] An analysis from the American National Registry of Myocardial Infarction[@b7-cia-11-1309] noted an interaction between sex and age with regard to 30-day mortality. There was a progressive decrease in the difference (higher mortality in females) with increasing age until the age of 75 years. Study results for sex differences in the prevalence of and outcome for AMI among patients over 75 years of age have not been described as well as they have been described for middle-aged patients.

Both female sex and increasing age have been reported to be risk factors for atypical symptoms and a less aggressive treatment in AMI.[@b8-cia-11-1309] Therefore, it is of interest to compare females and males when both criteria are fulfilled, that is, to look at sex differences among the elderly patients.

This study analyzed age-adjusted sex differences among AMI patients aged 75 years and above with regard to 7-year mortality (primary end point) and the frequency of angiograms and admission to the coronary care unit (CCU) as well as 1-year mortality (secondary end points).

Patients and methods
====================

This study was performed at Sahlgrenska University Hospital in Gothenburg. The hospital has facilities for emergency percutaneous coronary intervention at all hours of the week. Gothenburg is the second largest city in Sweden and has 550,000 inhabitants, 7% of whom are aged 75 years and above.[@b9-cia-11-1309]

We collected data during two distinct periods, 2001/2002 and 2007, to evaluate possible changes over time. We have previously described these periods,[@b10-cia-11-1309] and the first period was furthermore described in a comparison between patients living in Minneapolis/St Paul and Gothenburg.[@b11-cia-11-1309]

Patients and data collection
----------------------------

All patients admitted to the Sahlgrenska University Hospital with a final diagnosis of AMI during the two periods (from July 1, 2001 to June 30, 2002 and from January 1, 2007 to December 31, 2007), regardless of whether or not they were admitted to the CCU, were registered. Patients who were residents of Gothenburg and aged 75 years and above were included in this analysis. All data were retrospectively recorded.

A diagnosis of AMI was based on the assessment by the responsible hospital physicians. It was recommended that the diagnosis should be based on a dynamic serial elevation of isoenzyme creatine kinase-MB \>5 µg/L or troponin T \>0.05 µg/L, or an equivalent increase in troponin I plus at least one further criterion (eg, typical chest pain or electrocardiographic signs of acute myocardial ischemia).[@b12-cia-11-1309]--[@b14-cia-11-1309]

A 12-lead electrocardiogram (ECG) was recorded on admission to the hospital. The ECG definition of acute myocardial ischemia in the absence of left bundle branch block (LBBB), right bundle branch block, and pacemaker rhythm was ST-segment elevation at the J point in two contiguous leads with the cutoff points of ≥1 mm (0.1 mV) in all leads other than leads V2--V3, where the cutoff points of ≥2 mm (0.2 mV) in males and ≥1.5 mm (0.15 mV) in females applied. In cases of ST-segment depression, the changes regarded as manifestations of acute myocardial ischemia were a downsloping ST segment with a J-point depression of ≥0.5 mm (0.05 mV) in at least two contiguous leads. "Contiguous leads" refer to anterior leads (V~1~--V~6~), inferior leads (II, III, aVF), or lateral/apical leads (I, aVL).[@b14-cia-11-1309] When the V~4~R lead was recorded instead of the V~3~ lead, an ST-segment elevation of 0.5 mm (0.05 mV) or greater was regarded as a sufficient ECG criterion for acute myocardial ischemia.[@b14-cia-11-1309]

In the presence of LBBB, a new LBBB in comparison with the previous ECGs, such as a prehospital ECG, would fulfill the criterion for acute myocardial ischemia. Similarly, if a new ST-segment elevation or a new Q-wave is found in the presence of right bundle branch block, the ECG criteria for acute myocardial ischemia would be fulfilled.[@b14-cia-11-1309]

In the event of suspected MI, other investigative cardiac procedures, such as an exercise bicycle test, echocardiography test, and coronary angiography were considered to obtain a final diagnosis. A recurrent MI was considered to be present if the features of AMI started from the 28th day or later following the first incident of AMI and the criteria for acute myocardial ischemia were fulfilled.[@b14-cia-11-1309] A reinfarction was considered to be present if an AMI occurred within 28 days of the first incident of AMI or within 28 days of a recurrent MI.[@b14-cia-11-1309]

Previous history, smoking habits, ECG records, cardiac treatment procedures, cardiovascular complications, medical treatment, and events after discharge within 1 year of admission to hospital were extracted from the database of the health care system by specially trained monitoring nurses. The date of admission to hospital and the date of discharge from hospital were registered. There was a 7-year follow-up for mortality. The date of death was obtained from the Swedish National Population Register, together with survival confirmation.

Statistical analysis
--------------------

All percentages are presented as crude results (ie, not adjusted for age). For comparisons of age between sexes, the Mann--Whitney *U*-test was used; otherwise *P*-values, including the calculation of odds ratios (ORs) for two of the secondary objectives (admission to the CCU and performance of coronary angiography), were age adjusted using multiple logistic regression. Multiple logistic regression analysis was also used to analyze the interaction between sex and time period. The Kaplan--Meier method was used to estimate mortality, as well as for cardiovascular event rates after hospital discharge. The Cox proportional hazards model was used for age-adjusted *P*-values and time period by sex interaction in terms of mortality and event rates and to calculate the hazard ratio (HR) with corresponding 95% confidence intervals (CIs). For the analysis of mortality and event rates after discharge, only the first admission for those with multiple visits was included. All tests were two-sided, and a *P*-value of \<0.05 was considered statistically significant for 7-year mortality (primary objective), otherwise a *P*-value of \<0.01 was required for statistical significance. All analyses were performed using SAS v9.3 software (SAS Institute Inc., Cary, NC, USA). Approval for this study was given by the Research Ethics Committee at Gothenburg University, Guldhedsgatan 5A, SE-413 20 Gothenburg, Sweden. This study was retrospective and the Research Ethics Committee at Gothenburg University deemed informed consent not necessary.

Results
=======

In total, there were 1,414 elderly patients with a final diagnosis of AMI in both periods (2001/2002 and 2007), including 748 (53%) females and 666 (47%) males. The distribution of sexes was similar in the two periods.

Baseline characteristics and admission to CCU
---------------------------------------------

Females were older and had a lower prevalence of previous AMI and coronary artery bypass grafting (CABG) but a higher prevalence of diagnosed hypertension. A history of renal disease was more common among males, more so in 2001/2002 than in 2007. Males were admitted to the CCU (secondary end point) more frequently than females, age-adjusted OR for males vs females was 1.38 (95% CI 1.11, 1.72, *P*=0.004). The duration of hospital stay was similar in both females and males ([Table 1](#t1-cia-11-1309){ref-type="table"}).

Symptoms, ECG, cardiovascular events, and treatment in hospital
---------------------------------------------------------------

The proportion of patients with symptoms of chest pain, cardiogenic shock, and congestive heart failure on admission to hospital did not differ significantly between females and males ([Table 2](#t2-cia-11-1309){ref-type="table"}).

Sixty-five percent of the patients had an ECG recorded on admission to the hospital. Among them, ST-segment elevation, especially with a location in the anterior leads, occurred more frequently in females, while LBBB was more frequent in males.

There was no statistically significant difference for the secondary end point of coronary angiography, and age-adjusted OR for males vs females was 1.34 (95% CI 1.00, 1.79, *P*=0.05) ([Table 3](#t3-cia-11-1309){ref-type="table"}). The proportions of females and males who underwent other cardiac procedures, including reperfusion therapy, did not differ significantly, except for CABG, which was performed significantly more frequently in males ([Table 3](#t3-cia-11-1309){ref-type="table"}).

[Table 3](#t3-cia-11-1309){ref-type="table"} also shows that there was no significant difference in the frequency of various complications in relation to AMI between males and females.

Medication at discharge
-----------------------

There was no statistically significant difference between females and males with regard to medication at discharge from hospital ([Table 4](#t4-cia-11-1309){ref-type="table"}).

Outcomes in hospital and during follow-up
-----------------------------------------

Of all the patients, 18% died during hospitalization in both sex groups ([Table 3](#t3-cia-11-1309){ref-type="table"}).

Among the patients who were alive at discharge from hospital, 29% of females and 33% of males died within 1 year of their index admission ([Table 5](#t5-cia-11-1309){ref-type="table"}). There were no statistically significant differences regarding AMI or stroke after hospital discharge between males and females during 1 year after index admission.

The 7-year mortality rate was above 80% for both males and females during both time periods ([Figure 1](#f1-cia-11-1309){ref-type="fig"}), although there was a statistically significant difference between the sexes for this parameter (the primary end point) when adjusting for age, with an HR (males vs females) of 1.16 (95% CI 1.03, 1.31, *P*=0.02). For the two separate time periods, the HR was 1.20 (95% CI 1.02, 1.41, *P*=0.02) in 2001/2002 and 1.12 (95% CI 0.93, 1.35, *P*=0.23) in 2007.

For death during the first year following index AMI admission including in-hospital mortality (secondary objective), there was a nonsignificant trend toward higher mortality among males than females, with an age-adjusted HR of 1.18 (95% CI 0.99, 1.39, *P*=0.06). When adjusting also for all previous history variables ([Table 1](#t1-cia-11-1309){ref-type="table"}), HR for 7-year mortality was 1.13 (95% CI 0.99, 1.30, *P*=0.07), and HR for 1-year mortality was 1.11 (95% CI 0.92, 1.34, *P*=0.28).

Discussion
==========

This study is a comparison between females and males over the age of 75 years with regard to the diagnosis of AMI and survival follow-up data of all patients for more than 7 years. The primary end point was mortality after 7 years, and during that period, the mortality was as high as above 80% for both sexes. Males had higher age-adjusted 7-year mortality than females. For one of the secondary end points, that is, mortality (including in-hospital mortality) during 1 year, there was no statistically significant difference between the sexes. Previous surveys have shown higher mortality in females in both short- and long-term outcomes,[@b15-cia-11-1309],[@b16-cia-11-1309] which differs from our results in this respect and the explanation is not clear.

Males showed a significantly higher admission rate to the CCU than females. Similar findings were reported in previous studies.[@b17-cia-11-1309] The reason behind this finding is not known, but it has even been discussed in terms of inappropriate sex bias. Age, previous MI and/or CABG, and clinical symptoms seem to be the factors predicting the initial degree of suspicion of AMI.[@b18-cia-11-1309] In our study, when adjusting for age and previous MI and/or CABG, rate of CCU admission was still significantly higher in males than females (OR 1.38 \[95% CI 1.10, 1.72\]). We speculated that a higher prevalence of clinical severity in males than in females might be the main reason. Unfortunately, the registrations were not available to us to test this hypothesis.

Some of the previous studies showed a lower rate of invasive therapy for AMI among females when compared with males,[@b19-cia-11-1309] but others reported the opposite results.[@b20-cia-11-1309] In our study, CABG was performed more frequently in males than in females. The reason for this finding might be that extensive coronary artery disease is more frequent in males than in females.[@b21-cia-11-1309] A higher rate of previous MI or CABG and the more frequent presence of LBBB might also indicate more extensive coronary artery disease in males. We did not find significant sex differences in any other indices of potential revascularization. The use of coronary angiography was one of our secondary end points for which there was no statistically significant difference between the sexes (age-adjusted OR 1.34 \[95% CI 1.00, 1.79\]).

Other aspects of therapy, such as medication at discharge from hospital, did not differ between the sexes, in line with previous reporting.[@b22-cia-11-1309] Other studies have reported that beta-blockers and angiotensin-converting enzyme inhibitors were used more frequently in males than in females.[@b23-cia-11-1309] Both these medicines have been shown to reduce mortality in AMI patients.[@b24-cia-11-1309]

In this study population, females were older than males and had a lower prevalence of previous MI. Our findings are in agreement with those reported in the literature.[@b23-cia-11-1309],[@b25-cia-11-1309]

In a population of young patients with previous AMI, a higher prevalence of hypertension was found in males. However, in those over 40 years of age, opposite results were found.[@b15-cia-11-1309] In our study, females had a higher prevalence of previous hypertension, which is in agreement with that reported by other studies.[@b15-cia-11-1309],[@b23-cia-11-1309],[@b25-cia-11-1309]

Previous studies have suggested that, for anatomic reasons, ST-elevation myocardial infarction (STEMI) is less frequent in females than in males.[@b26-cia-11-1309] In our region, the Västra Götaland region of Sweden, a study in 2008 of unselected patients with AMI found a similar degree of ST deviation in both sexes.[@b25-cia-11-1309] In the present study, STEMI was more frequent in females than in males. The mechanism behind this observation is unclear. We speculate that AMIs in elderly patients might differ from those in younger patients.[@b27-cia-11-1309] However, a lack of availability of ECGs recorded on admission to hospital in both study periods might have influenced this finding. There was a lower prevalence of LBBB in females, which is in agreement with the previous observations.[@b23-cia-11-1309],[@b25-cia-11-1309]

Strengths and limitations of the study
======================================

The main strength of this study is that all elderly patients hospitalized with an AMI in a certain catchment area were included and followed for a long period, with 7-year mortality data for all patients.

Furthermore, the study population is unselected and has a high degree of representativeness, as all patients with a final diagnosis of AMI were included, regardless of whether or not they were admitted to the CCU. The date of death was obtained from the Swedish National Population Register, which has a high degree of quality control and high validity.

One limitation of this study was the retrospective collection of data. As a result, some information was missing. The availability of ECGs registered in the emergency room on admission was low in the first study period. This might influence the ECG findings and limit our opportunity to draw the correct conclusions. We presume that prehospital ECGs and ECGs monitored during ambulance transport were used instead of ECGs recorded in the emergency department.[@b28-cia-11-1309] Unfortunately, these registrations were not available to us.

Another limitation was that the AMI diagnosis was based on the official clinical judgment and not on study-specific criteria. On the other hand, this reflects the real-world situation. We also lacked information about the causes of death during follow-up.

Finally, patients were recruited some years ago, and treatment routines for AMI differ in some respects today as compared with the time of the surveys.

Conclusion
==========

In this study population, males had higher age-adjusted 7-year mortality and higher rate of admission to the CCU than females. One-year mortality did not differ significantly between females and males, nor did the frequency of performed coronary angiograms.

The mortality was high for both sexes, both in the first year and during the 7-year follow-up. From our results, there seems to be room for improvement at all levels of care for these elderly patients. This includes providing initial CCU treatment, invasive investigations, revascularization procedures, and medication.

Basically, these elderly patients should be treated according to the guidelines[@b29-cia-11-1309]--[@b31-cia-11-1309] to a maximum extent possible, while keeping in mind their individual needs.
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###### 

Baseline characteristics of the elderly patients with AMI

  Characteristics                    2001/2002                                       2007                                            2001/2002+2007                                  *P*-value[a](#tfn1-cia-11-1309){ref-type="table-fn"}   *P*-value[b](#tfn2-cia-11-1309){ref-type="table-fn"}                                                              
  ---------------------------------- ----------------------------------------------- ----------------------------------------------- ----------------------------------------------- ------------------------------------------------------ ------------------------------------------------------ ----------------------------------------------- ---------- --------
  Age (mean ± SD; years)             84±5                                            83±5                                            85±5                                            83±5                                                   84±5                                                   83±5                                            \<0.0001   0.49
  Previous medical history (%)                                                                                                                                                                                                                                                                                                                                
   AMI                               35                                              50[c](#tfn3-cia-11-1309){ref-type="table-fn"}   42                                              43[c](#tfn3-cia-11-1309){ref-type="table-fn"}          38                                                     47[c](#tfn3-cia-11-1309){ref-type="table-fn"}   0.0001     0.01
   CABG                              6                                               10                                              8                                               18[c](#tfn3-cia-11-1309){ref-type="table-fn"}          7                                                      13                                              0.001      0.21
   PCI                               3                                               3                                               11                                              9[c](#tfn3-cia-11-1309){ref-type="table-fn"}           7                                                      6                                               0.16       0.75
   Angina pectoris                   46[c](#tfn3-cia-11-1309){ref-type="table-fn"}   48[c](#tfn3-cia-11-1309){ref-type="table-fn"}   28[c](#tfn3-cia-11-1309){ref-type="table-fn"}   35[c](#tfn3-cia-11-1309){ref-type="table-fn"}          38[c](#tfn3-cia-11-1309){ref-type="table-fn"}          42[c](#tfn3-cia-11-1309){ref-type="table-fn"}   0.04       0.21
   Cardiac arrest                    \<1                                             2                                               0                                               0[c](#tfn3-cia-11-1309){ref-type="table-fn"}           \<1                                                    \<1                                             0.51       1.00
   Congestive heart failure          38                                              44                                              33                                              26                                                     36                                                     36                                              0.27       0.01
   Atrial fibrillation               23                                              30                                              27                                              24[c](#tfn3-cia-11-1309){ref-type="table-fn"}          25                                                     28                                              0.07       0.04
   Hypertension                      58                                              51                                              60[c](#tfn3-cia-11-1309){ref-type="table-fn"}   53[c](#tfn3-cia-11-1309){ref-type="table-fn"}          59[c](#tfn3-cia-11-1309){ref-type="table-fn"}          53[c](#tfn3-cia-11-1309){ref-type="table-fn"}   0.004      0.93
   Cerebrovascular disease           25                                              22                                              23                                              19                                                     24                                                     21                                              0.12       0.76
   Peripheral vascular disease       12[c](#tfn3-cia-11-1309){ref-type="table-fn"}   18                                              12                                              13                                                     12                                                     16                                              0.07       0.20
   Diabetes                          20                                              22                                              28                                              25                                                     23                                                     23                                              0.53       0.19
   Renal disease                     3[c](#tfn3-cia-11-1309){ref-type="table-fn"}    15                                              11                                              12                                                     7                                                      13                                              \<0.0001   0.0001
   COPD                              11                                              12                                              13                                              12[c](#tfn3-cia-11-1309){ref-type="table-fn"}          12                                                     12                                              0.75       0.32
   Connective tissue disease         4                                               2                                               0                                               0                                                      2                                                      1                                               0.23       1.00
   Cancer                            4[c](#tfn3-cia-11-1309){ref-type="table-fn"}    8[c](#tfn3-cia-11-1309){ref-type="table-fn"}    10                                              12                                                     7                                                      9                                               0.08       0.27
  Current smoking (%)                9[e](#tfn5-cia-11-1309){ref-type="table-fn"}    12[d](#tfn4-cia-11-1309){ref-type="table-fn"}   8[c](#tfn3-cia-11-1309){ref-type="table-fn"}    8[c](#tfn3-cia-11-1309){ref-type="table-fn"}           8[d](#tfn4-cia-11-1309){ref-type="table-fn"}           10[c](#tfn3-cia-11-1309){ref-type="table-fn"}   0.65       0.40
  Admitted to CCU (%)                39                                              53                                              34                                              38                                                     36                                                     47                                              0.004      0.04
  Duration of hospital stay (days)   6                                               7                                               6                                               5                                                      6                                                      6                                               0.75       0.32

**Notes:**

For difference between all females and all males (age adjusted, except age comparison);

for time period by sex interaction;

1%--5% missing;

5%--10% missing;

10%--25% missing.

**Abbreviations:** AMI, acute myocardial infarction; CABG, coronary artery bypass grafting; PCI, percutaneous coronary intervention; COPD, chronic obstructive pulmonary disease; CCU, coronary care unit.

###### 

Clinical symptoms and ECG findings (%)

  Characteristics                                                       2001/2002                                       2007                                            2001/2002+2007                                  *P*-value[a](#tfn7-cia-11-1309){ref-type="table-fn"}   *P*-value[b](#tfn8-cia-11-1309){ref-type="table-fn"}                                                            
  --------------------------------------------------------------------- ----------------------------------------------- ----------------------------------------------- ----------------------------------------------- ------------------------------------------------------ ------------------------------------------------------ ----------------------------------------------- -------- ------
  Clinical symptoms                                                                                                                                                                                                                                                                                                                                                                            
   Chest pain/pressure/discomfort                                       80[c](#tfn9-cia-11-1309){ref-type="table-fn"}   86[c](#tfn9-cia-11-1309){ref-type="table-fn"}   73[c](#tfn9-cia-11-1309){ref-type="table-fn"}   74[c](#tfn9-cia-11-1309){ref-type="table-fn"}          77[c](#tfn9-cia-11-1309){ref-type="table-fn"}          81[c](#tfn9-cia-11-1309){ref-type="table-fn"}   0.04     0.22
   Pulmonary edema or cardiogenic shock                                 6                                               8[c](#tfn9-cia-11-1309){ref-type="table-fn"}    9                                               9                                                      8                                                      8                                               0.60     0.47
   Congestive heart failure                                             43                                              41                                              51[c](#tfn9-cia-11-1309){ref-type="table-fn"}   40[c](#tfn9-cia-11-1309){ref-type="table-fn"}          46[c](#tfn9-cia-11-1309){ref-type="table-fn"}          40                                              0.14     0.14
  ECG recording available[d](#tfn10-cia-11-1309){ref-type="table-fn"}   49                                              50                                              84                                              85                                                     65                                                     65                                              0.82     0.88
  ST elevation                                                          15                                              9                                               15                                              8                                                      15                                                     9                                               0.004    0.90
   Location                                                                                                                                                                                                                                                                                                                                                                                    
    Anterior                                                            13                                              7                                               12                                              5                                                      12                                                     6                                               0.0009   0.59
    Inferior                                                            4                                               3                                               5                                               4                                                      5                                                      3                                               0.25     0.64
    Lateral                                                             \<1                                             \<1                                             1                                               0                                                      \<1                                                    \<1                                             0.37     0.41
  ST depression                                                         35                                              20                                              28                                              26                                                     31                                                     23                                              0.02     0.02
   LBBB                                                                 9                                               19                                              10                                              18                                                     10                                                     18                                              0.0003   0.59
   Other pathological ECG changes                                       50                                              53                                              41                                              49                                                     45                                                     51                                              0.09     0.43
   Sinus rhythm                                                         72                                              68                                              72                                              67                                                     72                                                     68                                              0.07     0.97
   Normal ECG                                                           24                                              21                                              29                                              22                                                     27                                                     22                                              0.08     0.52

**Notes:**

For difference between all females and all males (age adjusted);

for time period by sex interaction;

1%--5% missing;

refers to patients with available ECG recordings.

**Abbreviations:** ECG, electrocardiogram; LBBB, left bundle branch block.

###### 

Cardiac procedures, reperfusion therapy, complications, and death during hospitalization (%)

  Procedures and complications       2001/2002   2007                                              2001/2002+2007   *P*-value[a](#tfn12-cia-11-1309){ref-type="table-fn"}   *P*-value[b](#tfn13-cia-11-1309){ref-type="table-fn"}                                                             
  ---------------------------------- ----------- ------------------------------------------------- ---------------- ------------------------------------------------------- ------------------------------------------------------- ------------------------------------------------- ------- ------
  **Cardiac procedures**                                                                                                                                                                                                                                                                      
  Exercise bicycle test              5           11                                                2                2[c](#tfn14-cia-11-1309){ref-type="table-fn"}           4                                                       7                                                 0.04    0.09
  Echocardiography                   33          42                                                31               42                                                      32                                                      42                                                0.02    0.78
  Coronary angiography               9           15                                                20               29                                                      14                                                      21                                                0.05    0.70
  **Reperfusion therapy**                                                                                                                                                                                                                                                                     
  Thrombolysis                       6           5                                                 \<1              0                                                       3                                                       3                                                 0.52    0.91
  PCI                                5           5                                                 14               22                                                      9                                                       12                                                0.31    0.23
   Rescue                            1           \<1                                               0                0                                                       \<1                                                     \<1                                               0.45    1.00
   Primary                           4           4                                                 12               20                                                      7                                                       11                                                0.14    0.34
   Elective                          \<1         0                                                 2                2                                                       1                                                       \<1                                               0.44    1.00
  CABG                               1           6                                                 2                3                                                       1                                                       4                                                 0.007   0.14
  **Complications**                                                                                                                                                                                                                                                                           
  Reinfarction                       2           4[c](#tfn14-cia-11-1309){ref-type="table-fn"}     2                3                                                       2                                                       4                                                 0.01    0.65
  Cardiogenic shock                  2           3[c](#tfn14-cia-11-1309){ref-type="table-fn"}     2                3                                                       2                                                       3[c](#tfn14-cia-11-1309){ref-type="table-fn"}     0.55    0.94
  Hemorrhage requiring transfusion   2           5[c](#tfn14-cia-11-1309){ref-type="table-fn"}     5                5                                                       3                                                       5[c](#tfn14-cia-11-1309){ref-type="table-fn"}     0.07    0.11
  Hypotension                        11          15[c](#tfn14-cia-11-1309){ref-type="table-fn"}    17               16                                                      14                                                      15[c](#tfn14-cia-11-1309){ref-type="table-fn"}    0.43    0.07
  Pulmonary embolism                 \<1         \<1[c](#tfn14-cia-11-1309){ref-type="table-fn"}   2                1                                                       1                                                       \<1[c](#tfn14-cia-11-1309){ref-type="table-fn"}   0.45    1.00
  Stroke                             7           4[c](#tfn14-cia-11-1309){ref-type="table-fn"}     2                4                                                       5                                                       4[c](#tfn14-cia-11-1309){ref-type="table-fn"}     0.45    0.03
  Deep vein thrombosis               \<1         1[c](#tfn14-cia-11-1309){ref-type="table-fn"}     0                \<1                                                     \<1                                                     \<1[c](#tfn14-cia-11-1309){ref-type="table-fn"}   0.06    1.00
  Congestive heart failure           51          51[c](#tfn14-cia-11-1309){ref-type="table-fn"}    19               15                                                      37                                                      36                                                0.95    0.25
  Acute renal failure                3           5[c](#tfn14-cia-11-1309){ref-type="table-fn"}     2                2                                                       3                                                       4[c](#tfn14-cia-11-1309){ref-type="table-fn"}     0.18    0.29
  Pneumonia                          8           14[c](#tfn14-cia-11-1309){ref-type="table-fn"}    7                7                                                       8                                                       11[c](#tfn14-cia-11-1309){ref-type="table-fn"}    0.03    0.21
  Pericarditis                       0           \<1[c](#tfn14-cia-11-1309){ref-type="table-fn"}   0                \<1                                                     0                                                       \<1[c](#tfn14-cia-11-1309){ref-type="table-fn"}   0.51    1.00
  Death                              17          20                                                20               16                                                      18                                                      18                                                0.73    0.12

**Notes:**

For difference between all females and all males (age adjusted);

for time period by sex interaction;

1%--5% missing.

**Abbreviations:** AMI, acute myocardial infarction; PCI, percutaneous coronary intervention; CABG, coronary artery bypass grafting.

###### 

Medication at discharge (of those discharged alive \[%\])

  Medication                   2001/2002   2007   2001/2002+2007   *P*-value[a](#tfn16-cia-11-1309){ref-type="table-fn"}   *P*-value[b](#tfn17-cia-11-1309){ref-type="table-fn"}               
  ---------------------------- ----------- ------ ---------------- ------------------------------------------------------- ------------------------------------------------------- ---- ------ ------
  Anticoagulants               12          14     14               19                                                      13                                                      16   0.15   0.70
  Aspirin                      84          83     79               83                                                      82                                                      83   0.51   0.23
  Nitrates                     42          45     62               66                                                      51                                                      54   0.15   0.95
  Digitalis                    16          13     11               7                                                       14                                                      10   0.06   0.53
  Diuretics                    68          66     66               58                                                      67                                                      63   0.34   0.19
  Beta-blockers                85          82     82               85                                                      84                                                      83   0.52   0.11
  Calcium channel blockers     15          15     14               14                                                      15                                                      15   0.77   0.82
  ACE inhibitors/A2-blockers   34          40     38               41                                                      36                                                      41   0.18   0.52
  Lipid-lowering agents        22          32     49               58                                                      34                                                      43   0.04   0.38

**Notes:**

For difference between all females and all males (age adjusted);

for time period by sex interaction.

**Abbreviation:** ACE, angiotensin-converting enzyme.

###### 

Cardiovascular events and death after hospital discharge within 1 year of admission to the hospital (of those discharged alive, only first admission included \[%\])

  Cardiovascular events and deaths   2001/2002                                        2007   2001/2002+2007                                    *P*-value[a](#tfn19-cia-11-1309){ref-type="table-fn"}   *P*-value[b](#tfn20-cia-11-1309){ref-type="table-fn"}               
  ---------------------------------- ------------------------------------------------ ------ ------------------------------------------------- ------------------------------------------------------- ------------------------------------------------------- ---- ------ ------
  Recurrent myocardial infarction    14[c](#tfn21-cia-11-1309){ref-type="table-fn"}   24     17                                                16                                                      15[c](#tfn21-cia-11-1309){ref-type="table-fn"}          21   0.03   0.03
  Coronary angiography               4[c](#tfn21-cia-11-1309){ref-type="table-fn"}    7      3[c](#tfn21-cia-11-1309){ref-type="table-fn"}     6                                                       4[c](#tfn21-cia-11-1309){ref-type="table-fn"}           7    0.17   0.72
  PCI                                2[c](#tfn21-cia-11-1309){ref-type="table-fn"}    3      1[c](#tfn21-cia-11-1309){ref-type="table-fn"}     3                                                       2[c](#tfn21-cia-11-1309){ref-type="table-fn"}           3    0.56   0.40
  CABG                               1[c](#tfn21-cia-11-1309){ref-type="table-fn"}    5      \<1[c](#tfn21-cia-11-1309){ref-type="table-fn"}   1                                                       \<1[c](#tfn21-cia-11-1309){ref-type="table-fn"}         4    0.02   0.54
  Stroke                             6[c](#tfn21-cia-11-1309){ref-type="table-fn"}    4      1[c](#tfn21-cia-11-1309){ref-type="table-fn"}     \<1                                                     4[c](#tfn21-cia-11-1309){ref-type="table-fn"}           2    0.12   0.64
  Death                              28                                               32     31                                                33                                                      29                                                      33   0.02   0.55

**Notes:**

For difference between all females and all males (age adjusted);

for time period by sex interaction;

1%--5% missing.

**Abbreviations:** PCI, percutaneous coronary intervention; CABG, coronary artery bypass grafting.
